Greater use of cloud-based collaboration and more department head involvement results in dramatic business benefits. This report is based on a global survey conducted by Forbes Insights ...
A collaboration between a drug plan and clinical pharmacists led to nearly 50% of members successfully switching to a preferred dipeptidyl-peptidase-4 inhibitor.
The investigations included interviews with 18 people. We found several barriers blocking the benefits of industry collaboration, including a common mistrust of partnerships with pharmaceutical ...